This article contains several brief extracts from the report of the Technical Review Panel (TRP) on the funding requests it reviewed in Windows 1 and 2 of the 2017-2019 allocation period. The extracts are from Part Two of the report (technical observations).
TRP provides comments on requests submitted to the Global Fund in the first two windows of 2017-2019
Philippines’ HIV funding request to the Global Fund contains a good mix of prevention and treatment: TRP
The Philippines’ HIV funding request was strategically focused with appropriately targeted investments towards HIV prevention programs for key populations, and access to testing and treatment services. This was the conclusion of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) when they reviewed the request.
In line with the Global Fund’s eligibility policy, Cuba is no longer eligible for regular Global Fund financing, and so it had submitted a funding request tailored to transition for its HIV component.
Bangladesh’s “ambitious, but realistic” TB funding request to the Global Fund receives positive reviews
The TB funding request submitted by the Bangladesh CCM received positive reviews from the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC). The two grants emanating from the request were approved by the Board on 17 October. A total of $110.9 million was approved, reflecting the total TB allocation for Bangladesh of $97.9 million and an additional $13.0 million in catalytic matching funds.
Global Fund expresses concern over Benin’s plan to shift funds away from HIV and malaria towards an RSSH funding request
When it reviewed the funding requests from Benin, the Grant Approvals Committee (GAC) and the Technical Review Panel (TRP) expressed serious concerns about what they perceived as gaps in Benin’s HIV and malaria programs – which, they said, were partly due to the decision of the country coordinating mechanism (CCM) to shift some of its allocation towards an RSSH funding request.
The original allocation for Benin was as follows:
The two TB/HIV grants to Malawi which the Board approved on 17 October do not differ significantly from the funding request, which was submitted on 20 March 2017. GFO detailed the contents of the request in an article in GFO 316 on 19 July.
Zimbabwe’s new Global Fund grants for TB/HIV are clearly aligned to the country’s epi profile and its national strategic plans, TRP says
In their recommendation to the Board on Zimbabwe’s TB/HIV funding request, the Technical Review Panel (TRP) and the Grants Approvals Committee (GAC) commented favorably on Zimbabwe’s inclusion of interventions to address barriers related to human rights and gender, and its focus on key populations for HIV, TB and STI care and treatment.